-
Je něco špatně v tomto záznamu ?
The evaluation of formulations for the preparation of new formula pellets
J. Gajdziok, J. Bernatoniene, J. Muselík, R. Masteiková, K. Dvořáčková, Z. Petkeviciute, R. Lazauskas, Z. Kalveniene, R. Bernatoniene,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- celulosa chemie MeSH
- chemické jevy MeSH
- Crataegus chemie MeSH
- Ginkgo biloba chemie MeSH
- pomocné látky chemie MeSH
- poréznost MeSH
- příprava léků metody MeSH
- rostlinné extrakty chemie MeSH
- srdečník chemie MeSH
- tobolky chemie MeSH
- tvrdost MeSH
- zvlhčující látky chemie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The aim of the study was to prepare pellets of maidenhair tree (Ginkgo biloba), motherwort (Leonurus cardiaca) and hawthorn (Crataegus monogyna) dry extracts by extrusion/spheronization method. The critical step of this process was the amount of added wetting liquid (water-ethanolic mixture) and the amount of extract in the formulation. The samples of pellets containing 30-50% of extracts were formulated: Pellets contained extracts of Ginkgo, Crataegi and Leonuri. The last sample was aimed at the formulation of pellets with the content of 30% of the mixture of Ginkgo, Leonuri and Crataegi extracts in a ratio of 1:5:6. The remainder of the solid compounds in all formulations was microcrystalline cellulose (Avicel® PH-101). It was not possible to find a way to adequately wet the formulations with the content of extracts higher than 30% because of the unsuitable properties of all three extracts used. On the basis of the experiments, pellets with mixtures of all three previously used extracts were prepared. These pellets showed perfect physico-mechanical properties: Hardness (10.00 ± 2.24 N), friability (0.06%), repose angle (20.99 ± 0.41°), flowability (6.97 ± 0.29 s/100g of pellets), sphericity (0.81 ± 0.05), compressibility index (4.65%), intraparticular porosity (0.09%) and interparticular porosity (45.11%), which predetermine them to other testing and usage (feeling into capsules, tableting, coating etc.).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022543
- 003
- CZ-PrNML
- 005
- 20170410094055.0
- 007
- ta
- 008
- 120806s2011 xxk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.3109/10837450.2010.502174 $2 doi
- 035 __
- $a (PubMed)20649408
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Gajdziok, Jan $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic.
- 245 14
- $a The evaluation of formulations for the preparation of new formula pellets / $c J. Gajdziok, J. Bernatoniene, J. Muselík, R. Masteiková, K. Dvořáčková, Z. Petkeviciute, R. Lazauskas, Z. Kalveniene, R. Bernatoniene,
- 520 9_
- $a The aim of the study was to prepare pellets of maidenhair tree (Ginkgo biloba), motherwort (Leonurus cardiaca) and hawthorn (Crataegus monogyna) dry extracts by extrusion/spheronization method. The critical step of this process was the amount of added wetting liquid (water-ethanolic mixture) and the amount of extract in the formulation. The samples of pellets containing 30-50% of extracts were formulated: Pellets contained extracts of Ginkgo, Crataegi and Leonuri. The last sample was aimed at the formulation of pellets with the content of 30% of the mixture of Ginkgo, Leonuri and Crataegi extracts in a ratio of 1:5:6. The remainder of the solid compounds in all formulations was microcrystalline cellulose (Avicel® PH-101). It was not possible to find a way to adequately wet the formulations with the content of extracts higher than 30% because of the unsuitable properties of all three extracts used. On the basis of the experiments, pellets with mixtures of all three previously used extracts were prepared. These pellets showed perfect physico-mechanical properties: Hardness (10.00 ± 2.24 N), friability (0.06%), repose angle (20.99 ± 0.41°), flowability (6.97 ± 0.29 s/100g of pellets), sphericity (0.81 ± 0.05), compressibility index (4.65%), intraparticular porosity (0.09%) and interparticular porosity (45.11%), which predetermine them to other testing and usage (feeling into capsules, tableting, coating etc.).
- 650 _2
- $a tobolky $x chemie $7 D002214
- 650 _2
- $a celulosa $x chemie $7 D002482
- 650 _2
- $a Crataegus $x chemie $7 D027825
- 650 _2
- $a příprava léků $x metody $7 D004339
- 650 _2
- $a pomocné látky $x chemie $7 D005079
- 650 _2
- $a Ginkgo biloba $x chemie $7 D020441
- 650 _2
- $a tvrdost $7 D006244
- 650 _2
- $a srdečník $x chemie $7 D031332
- 650 _2
- $a chemické jevy $7 D055598
- 650 _2
- $a rostlinné extrakty $x chemie $7 D010936
- 650 _2
- $a poréznost $7 D016062
- 650 _2
- $a zvlhčující látky $x chemie $7 D014906
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bernatoniene, Jurga
- 700 1_
- $a Muselík, Jan
- 700 1_
- $a Masteiková, Ruta
- 700 1_
- $a Dvořáčková, Kateřina
- 700 1_
- $a Petkeviciute, Zivile
- 700 1_
- $a Lazauskas, Robertas
- 700 1_
- $a Kalveniene, Zenona
- 700 1_
- $a Bernatoniene, Rūta
- 773 0_
- $w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 16, č. 5 (2011), s. 520-528
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20649408 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20170410094353 $b ABA008
- 999 __
- $a ok $b bmc $g 944456 $s 779840
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 16 $c 5 $d 520-528 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
- LZP __
- $a Pubmed-20120806/12/01